Bank of New York Mellon’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.6M Buy
128,106
+1,535
+1% +$174K ﹤0.01% 1687
2025
Q1
$13.3M Sell
126,571
-3,421
-3% -$360K ﹤0.01% 1713
2024
Q4
$13.9M Sell
129,992
-4,847
-4% -$519K ﹤0.01% 1750
2024
Q3
$13.5M Sell
134,839
-11,151
-8% -$1.12M ﹤0.01% 1783
2024
Q2
$12.3M Sell
145,990
-1,174
-0.8% -$98.9K ﹤0.01% 1853
2024
Q1
$10.8M Sell
147,164
-8,395
-5% -$614K ﹤0.01% 1918
2023
Q4
$11.1M Buy
155,559
+9,832
+7% +$702K ﹤0.01% 1928
2023
Q3
$8.73M Sell
145,727
-6,142
-4% -$368K ﹤0.01% 2023
2023
Q2
$10.9M Buy
151,869
+748
+0.5% +$53.9K ﹤0.01% 1908
2023
Q1
$11.1M Sell
151,121
-5,712
-4% -$420K ﹤0.01% 1885
2022
Q4
$10.5M Sell
156,833
-103,727
-40% -$6.93M ﹤0.01% 1914
2022
Q3
$14M Sell
260,560
-3,393
-1% -$182K ﹤0.01% 1698
2022
Q2
$14.7M Sell
263,953
-31,108
-11% -$1.73M ﹤0.01% 1716
2022
Q1
$20.7M Sell
295,061
-12,178
-4% -$855K ﹤0.01% 1656
2021
Q4
$29.6M Buy
307,239
+4,891
+2% +$471K 0.01% 1488
2021
Q3
$26.3M Sell
302,348
-2,184
-0.7% -$190K 0.01% 1567
2021
Q2
$24.9M Buy
304,532
+15,062
+5% +$1.23M ﹤0.01% 1604
2021
Q1
$27.5M Sell
289,470
-26,488
-8% -$2.52M 0.01% 1516
2020
Q4
$19.6M Sell
315,958
-18,510
-6% -$1.15M ﹤0.01% 1652
2020
Q3
$19.9M Sell
334,468
-22,142
-6% -$1.32M ﹤0.01% 1478
2020
Q2
$24.9M Sell
356,610
-18,155
-5% -$1.27M 0.01% 1306
2020
Q1
$17M Sell
374,765
-52,571
-12% -$2.38M 0.01% 1397
2019
Q4
$27.8M Sell
427,336
-55,026
-11% -$3.58M 0.01% 1377
2019
Q3
$30M Sell
482,362
-67,582
-12% -$4.2M 0.01% 1272
2019
Q2
$39.2M Sell
549,944
-2,732
-0.5% -$195K 0.01% 1116
2019
Q1
$43.3M Sell
552,676
-100,284
-15% -$7.86M 0.01% 1046
2018
Q4
$55.3M Sell
652,960
-145,699
-18% -$12.3M 0.02% 812
2018
Q3
$137M Sell
798,659
-26,529
-3% -$4.54M 0.04% 483
2018
Q2
$107M Sell
825,188
-7,514
-0.9% -$971K 0.03% 565
2018
Q1
$85.8M Sell
832,702
-11,135
-1% -$1.15M 0.02% 677
2017
Q4
$72.1M Sell
843,837
-141
-0% -$12K 0.02% 792
2017
Q3
$71.7M Sell
843,978
-53,992
-6% -$4.59M 0.02% 768
2017
Q2
$68M Buy
897,970
+11,614
+1% +$880K 0.02% 780
2017
Q1
$58.5M Buy
886,356
+30,883
+4% +$2.04M 0.02% 858
2016
Q4
$54.2M Buy
855,473
+77,034
+10% +$4.88M 0.02% 887
2016
Q3
$49.6M Sell
778,439
-5,710
-0.7% -$364K 0.01% 894
2016
Q2
$58.3M Sell
784,149
-161,337
-17% -$12M 0.02% 766
2016
Q1
$63.2M Buy
945,486
+73,367
+8% +$4.9M 0.02% 754
2015
Q4
$59M Sell
872,119
-108,681
-11% -$7.35M 0.02% 766
2015
Q3
$52.4M Buy
980,800
+7,163
+0.7% +$383K 0.02% 813
2015
Q2
$61.3M Buy
973,637
+361,467
+59% +$22.8M 0.02% 795
2015
Q1
$29.4M Buy
612,170
+276,739
+83% +$13.3M 0.01% 1219
2014
Q4
$11.1M Sell
335,431
-6,648
-2% -$221K ﹤0.01% 1853
2014
Q3
$10M Buy
342,079
+14,291
+4% +$419K ﹤0.01% 1894
2014
Q2
$12.7M Buy
327,788
+10,647
+3% +$414K ﹤0.01% 1771
2014
Q1
$13.3M Buy
317,141
+10,697
+3% +$449K ﹤0.01% 1717
2013
Q4
$10.1M Buy
306,444
+151,593
+98% +$4.97M ﹤0.01% 1883
2013
Q3
$4.18M Sell
154,851
-21,311
-12% -$575K ﹤0.01% 2342
2013
Q2
$4.11M Buy
+176,162
New +$4.11M ﹤0.01% 2315